SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Isaksson Helgi)
 

Search: WFRF:(Isaksson Helgi) > (2006-2009) > Impact of nandrolon...

  • Alsiö, JohanUppsala universitet,Funktionell farmakologi (author)

Impact of nandrolone decanoate on gene expression in endocrine systems related to the adverse effects of anabolic androgenic steroids

  • Article/chapterEnglish2009

Publisher, publication year, extent ...

  • Wiley,2009
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-124754
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-124754URI
  • https://doi.org/10.1111/j.1742-7843.2009.00439.xDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Elite athletes, body builders and adolescents misuse anabolic-androgenic steroids (AAS) in order to increase muscle mass or to enhance physical endurance and braveness. The high doses misused are associated with numerous adverse effects. The purpose of this study was to evaluate the impact of chronic supratherapeutic AAS treatment on circulating hormones and gene expression in peripheral tissues related to such adverse effects. Quantitative real-time PCR was used to measure expression levels of in total 37 genes (including peptide hormones, cell membrane receptors, nuclear receptors, steroid synthesising enzymes and other enzymes) in the pituitary, testes, adrenals, adipose tissue, kidneys and liver of male Sprague-Dawley rats after 14-day administration of the AAS nandrolone decanoate, 3 or 15 mg/kg. Plasma glucose and levels of adrenocorticotropic hormone (ACTH), adiponectin, corticosterone, ghrelin, insulin and leptin were also measured. We found several expected effects on the hypothalamic-pituitary-gonadal axis, while the treatment also caused a number of other not previously identified changes in circulating factors and gene transcription levels such as the dose-dependent reduction of the beta(3)-adrenergic receptor in adipose tissue, reduction of both circulating and mRNA levels of adiponectin, up-regulation of both hydroxymethylglutaryl-CoA-reductase, the rate-limiting enzyme in de novo synthesis of cholesterol, and the receptor for ACTH in the adrenals. The results provide evidence for wide ranging effects of AAS on the hypothalamic-pituitary-adrenal axis, adipose tissue and substrates of the renal control of blood pressure.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Birgner, CarolinaUppsala universitet,Institutionen för farmaceutisk biovetenskap (author)
  • Björkblom, LarsUppsala universitet,Funktionell farmakologi (author)
  • Isaksson, PernillaUppsala universitet,Funktionell farmakologi (author)
  • Bergström, LenaUppsala universitet,Institutionen för farmaceutisk biovetenskap,drogberoende och beteende(Swepub:uu)lbe24506 (author)
  • Schiöth, Helgi BUppsala universitet,Funktionell farmakologi(Swepub:uu)helgschi (author)
  • Lindblom, JonasUppsala universitet,Funktionell farmakologi(Swepub:uu)jli08577 (author)
  • Uppsala universitetFunktionell farmakologi (creator_code:org_t)

Related titles

  • In:Basic & Clinical Pharmacology & Toxicology: Wiley105:5, s. 307-3141742-78351742-7843

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view